Re: Oncological Benefit of Re-resection for T1 Bladder Cancer: A Comparative Effectiveness Study

Re: Oncological Benefit of Re-resection for T1 Bladder Cancer: A Comparative Effectiveness Study

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European urology 2022-07, Vol.82 (1), p.142-142
1. Verfasser: Alfred Witjes, J.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 142
container_issue 1
container_start_page 142
container_title European urology
container_volume 82
creator Alfred Witjes, J.
description
doi_str_mv 10.1016/j.eururo.2022.03.015
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2644937704</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0302283822017869</els_id><sourcerecordid>2644937704</sourcerecordid><originalsourceid>FETCH-LOGICAL-c226t-b76181cee7f943710db61280f647e19f2eff20f22ee07f60550f60ff7744bed73</originalsourceid><addsrcrecordid>eNp9kEtP6zAQRi10EZTHP0BXXrJJGD9ipyyQaMVLQkLisTapM0au0rjXTirx73FVYHlXs5jzfaM5hJwxKBkwdbEscYxjDCUHzksQJbBqj0xYrUWhKwV_yAQE8ILXoj4kRyktAUBUU3FADkUlpKpYNSHvz3hJn3obuvDhbdPRGfbo_ECDo89YRExoBx966kKkr4zOuqZtMdJ501uMl_SazsNq3cRm8BukN85t8U3uSIm-DGP7eUL2XdMlPP2ex-Tt9uZ1fl88Pt09zK8fC8u5GoqFVqxmFlG7qRSaQbtQjNfglNTIpo6jcxwc54ignYKqyitwTmspF9hqcUzOd73rGP6NmAaz8sli1zU9hjEZrqScCq1BZlTuUBtDShGdWUe_auKnYWC2bs3S7NyarVsDwmS3Ofb3-8K4WGH7G_qRmYGrHYD5z43HaJL1mD21PmYtpg3-_xe-AAnwi74</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2644937704</pqid></control><display><type>article</type><title>Re: Oncological Benefit of Re-resection for T1 Bladder Cancer: A Comparative Effectiveness Study</title><source>Access via ScienceDirect (Elsevier)</source><creator>Alfred Witjes, J.</creator><creatorcontrib>Alfred Witjes, J.</creatorcontrib><identifier>ISSN: 0302-2838</identifier><identifier>EISSN: 1873-7560</identifier><identifier>DOI: 10.1016/j.eururo.2022.03.015</identifier><identifier>PMID: 35346515</identifier><language>eng</language><publisher>Switzerland: Elsevier B.V</publisher><ispartof>European urology, 2022-07, Vol.82 (1), p.142-142</ispartof><rights>2022 European Association of Urology</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c226t-b76181cee7f943710db61280f647e19f2eff20f22ee07f60550f60ff7744bed73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.eururo.2022.03.015$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35346515$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Alfred Witjes, J.</creatorcontrib><title>Re: Oncological Benefit of Re-resection for T1 Bladder Cancer: A Comparative Effectiveness Study</title><title>European urology</title><addtitle>Eur Urol</addtitle><issn>0302-2838</issn><issn>1873-7560</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kEtP6zAQRi10EZTHP0BXXrJJGD9ipyyQaMVLQkLisTapM0au0rjXTirx73FVYHlXs5jzfaM5hJwxKBkwdbEscYxjDCUHzksQJbBqj0xYrUWhKwV_yAQE8ILXoj4kRyktAUBUU3FADkUlpKpYNSHvz3hJn3obuvDhbdPRGfbo_ECDo89YRExoBx966kKkr4zOuqZtMdJ501uMl_SazsNq3cRm8BukN85t8U3uSIm-DGP7eUL2XdMlPP2ex-Tt9uZ1fl88Pt09zK8fC8u5GoqFVqxmFlG7qRSaQbtQjNfglNTIpo6jcxwc54ignYKqyitwTmspF9hqcUzOd73rGP6NmAaz8sli1zU9hjEZrqScCq1BZlTuUBtDShGdWUe_auKnYWC2bs3S7NyarVsDwmS3Ofb3-8K4WGH7G_qRmYGrHYD5z43HaJL1mD21PmYtpg3-_xe-AAnwi74</recordid><startdate>202207</startdate><enddate>202207</enddate><creator>Alfred Witjes, J.</creator><general>Elsevier B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202207</creationdate><title>Re: Oncological Benefit of Re-resection for T1 Bladder Cancer: A Comparative Effectiveness Study</title><author>Alfred Witjes, J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c226t-b76181cee7f943710db61280f647e19f2eff20f22ee07f60550f60ff7744bed73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Alfred Witjes, J.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European urology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Alfred Witjes, J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Re: Oncological Benefit of Re-resection for T1 Bladder Cancer: A Comparative Effectiveness Study</atitle><jtitle>European urology</jtitle><addtitle>Eur Urol</addtitle><date>2022-07</date><risdate>2022</risdate><volume>82</volume><issue>1</issue><spage>142</spage><epage>142</epage><pages>142-142</pages><issn>0302-2838</issn><eissn>1873-7560</eissn><cop>Switzerland</cop><pub>Elsevier B.V</pub><pmid>35346515</pmid><doi>10.1016/j.eururo.2022.03.015</doi><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0302-2838
ispartof European urology, 2022-07, Vol.82 (1), p.142-142
issn 0302-2838
1873-7560
language eng
recordid cdi_proquest_miscellaneous_2644937704
source Access via ScienceDirect (Elsevier)
title Re: Oncological Benefit of Re-resection for T1 Bladder Cancer: A Comparative Effectiveness Study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-30T20%3A54%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Re:%20Oncological%20Benefit%20of%20Re-resection%20for%20T1%20Bladder%20Cancer:%20A%20Comparative%20Effectiveness%20Study&rft.jtitle=European%20urology&rft.au=Alfred%20Witjes,%20J.&rft.date=2022-07&rft.volume=82&rft.issue=1&rft.spage=142&rft.epage=142&rft.pages=142-142&rft.issn=0302-2838&rft.eissn=1873-7560&rft_id=info:doi/10.1016/j.eururo.2022.03.015&rft_dat=%3Cproquest_cross%3E2644937704%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2644937704&rft_id=info:pmid/35346515&rft_els_id=S0302283822017869&rfr_iscdi=true